cell therapy
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
In Brief This Week: GlaxoSmithKline, Precision Biosciences, LinusBio, Thermo Fisher Scientific
News items for the week of April 14, 2025.
Tevogen, Databricks Partner to Develop Immunotherapy Prediction Model
Databricks will contribute data engineering and AI expertise to support the development of Tevogen's PredicTcell technology.
Emory U Enrolling Heart Failure Patients into BioCardia's Follow-up CardiAMP Cell Therapy Trial
After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.
BrainStorm Submits IND Amendment Hoping to Move Ahead With Phase IIIb NurOwn ALS Trial
BrainStorm has attempted to gain market approval for NurOwn without success but remains committed to developing the cell therapy.